Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma
British Journal of Cancer, Published online: 25 November 2021; doi:10.1038/s41416-021-01640-2Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma
Source: British Journal of Cancer - Category: Cancer & Oncology Authors: Siteng Chen Liren Jiang Feng Gao Encheng Zhang Tao Wang Ning Zhang Xiang Wang Junhua Zheng Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Kidney Cancer | Learning | Renal Cell Carcinoma | UK Health | Universities & Medical Training